ATE441865T1 - Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila - Google Patents

Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila

Info

Publication number
ATE441865T1
ATE441865T1 AT05778861T AT05778861T ATE441865T1 AT E441865 T1 ATE441865 T1 AT E441865T1 AT 05778861 T AT05778861 T AT 05778861T AT 05778861 T AT05778861 T AT 05778861T AT E441865 T1 ATE441865 T1 AT E441865T1
Authority
AT
Austria
Prior art keywords
legionella pneumophila
vintro
isolation
prevention
polynucleotides
Prior art date
Application number
AT05778861T
Other languages
English (en)
Inventor
Jean-Philippe Arie
Camille Cyncynatus
Original Assignee
Ingen Biosciences
Univ Claude Bernard Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0407114A external-priority patent/FR2872289B1/fr
Priority claimed from FR0408714A external-priority patent/FR2874025B1/fr
Priority claimed from FR0413063A external-priority patent/FR2878861B1/fr
Application filed by Ingen Biosciences, Univ Claude Bernard Lyon filed Critical Ingen Biosciences
Application granted granted Critical
Publication of ATE441865T1 publication Critical patent/ATE441865T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05778861T 2004-06-29 2005-06-21 Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila ATE441865T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0407114A FR2872289B1 (fr) 2004-06-29 2004-06-29 Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila
FR0408714A FR2874025B1 (fr) 2004-08-06 2004-08-06 Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila
FR0413063A FR2878861B1 (fr) 2004-12-08 2004-12-08 Nouvelles proteines permettant la mise en evidence in vitro et la prevention des infections a legionella pneumophila
PCT/FR2005/001548 WO2006010805A2 (fr) 2004-06-29 2005-06-21 Nouveaux polypeptides pour la mise en evidence in vitro et la prevention des infections a legionella pneumophila

Publications (1)

Publication Number Publication Date
ATE441865T1 true ATE441865T1 (de) 2009-09-15

Family

ID=35169467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778861T ATE441865T1 (de) 2004-06-29 2005-06-21 Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila

Country Status (4)

Country Link
EP (1) EP1769249B1 (de)
AT (1) ATE441865T1 (de)
DE (1) DE602005016417D1 (de)
WO (1) WO2006010805A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2895519B1 (fr) * 2005-12-28 2008-12-19 Abag Sa Utilisation de la proteine 5e2 dans le diagnostic in vitro d'infection a legionella pneumophila
FR2930646B1 (fr) * 2008-04-29 2012-09-07 Abag Detection, in vitro, d'anticorps produits a la suite d'une infection a legionella pneumophila
US8785145B2 (en) 2011-08-11 2014-07-22 Ingen Biosciences Method for diagnosing gram-negative infections
EP2586789A1 (de) * 2011-08-11 2013-05-01 InGen Biosciences Verfahren zur Diagnose von gramnegativen Infektionen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610203D0 (en) * 1986-04-25 1986-05-29 Technology Licence Co Ltd Monoclonal antibodies
AU4337099A (en) * 1998-06-11 1999-12-30 St. Jude Children's Research Hospital Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof

Also Published As

Publication number Publication date
WO2006010805A2 (fr) 2006-02-02
EP1769249A2 (de) 2007-04-04
EP1769249B1 (de) 2009-09-02
WO2006010805A3 (fr) 2006-06-22
DE602005016417D1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
NZ627111A (en) Variants of activin iib receptor polypeptides and uses thereof
EA200901430A1 (ru) Варианты фермента аспарагиназы и их применение
EA201270517A1 (ru) Микобактериальные вакцины
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
NO20075927L (no) IL-21 varianter
IN2014CN02050A (de)
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2010144231A3 (en) Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
CY1111630T1 (el) Παραγωγα κυτοκινων
MX2010005816A (es) Epítopos de péptido de stat3.
ATE453663T1 (de) Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie
DE602005016417D1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen
DK1913020T3 (da) Immunogene konstrukter
WO2006097432A3 (de) Keratin-biktdende desmoplakinpolypeptidsequenzen
WO2004041859A3 (fr) Fragments peptidiques du facteur harp inhibant l'angiogenese
WO2009083968A8 (en) Novel protein
DE602007006493D1 (de) Peptide mit proliferationshemmender wirkung
WO2005077976A3 (en) Coiled-coil domains from c4b-binding protein
AU2007258875A8 (en) Recombinant novirhabdoviruses and uses thereof
SE0001988D0 (sv) Novel polypeptides and use thereof
GB0409559D0 (en) Polypeptide
DE602006017806D1 (de) Behandlung von neurodegeneration
ATE443715T1 (de) Polypeptide aus haemophilus influenza
WO2006125914A3 (fr) Utilisation de la protéine h11 dans le diagnostic in vitro d'infections à streptococcus pyogenes.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties